Gala Biotech

Gala Capabilities

Working with Gala

News

News - 2005

	November 15, 2005: Read about GPEx®, Gala's proprietary cell line development technology recently published in the September/October edition of Bioprocessing Journal
	July 8, 2005: Cardinal Health Completes Its First Manufacturing Project of an Antibody Using a Cell Line Made with Its Gene Expression Technology
	June 2005: Cardinal Health Enters Agreement For Mammalian Cell Line Engineered With Its GPEx® Patented Technology. "Cell Line to Express Experimental Cancer Antibody"
	May 2005: Gala Biotech, a Business Unit of Cardinal Health, Enters Cell Line Engineering Collaboration with Cambridge Antibody Technology
	April 2005: Cardinal Health Receives Patent for Mammalian Cell Genetic Engineering Technology

Gala Capabilities

Working with Gala

galainfo@catalent.com